• A
  • A
  • A

Recent Publications (July 2015 to August 2016)

Dr. Thomas V. Bilfinger

  1. LoGiurato B, Matthews R, Safaie E, Moore W, Bilfinger T, Relan N, Franceschi D.18F-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer. Nucl Med Commun. 2015 Sep;36(9):908-13. doi: 10.1097/MNM.0000000000000344.
  2. Chaudhry A, Grechushkin V, Hoshmand M, Kim CW, Pena A, Huston B, Chaya Y, Bilfinger T, Moore W.Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules. Medicine (Baltimore). 2015 Oct;94(42):e1672. doi: 10.1097/MD.0000000000001672.
  3. Moore W, Chaya Y, Chaudhry A, Depasquale B, Glass S, Lee S, Shin J, Mikhail G, Bhattacharji P, Kim B, Bilfinger T.Computed Tomography Assessment of Ablation Zone Enhancement in Patients With Early-Stage Lung Cancer After Stereotactic Ablative Radiotherapy. J Comput Assist Tomogr. 2015 Sep-Oct;39(5):804-9. doi: 10.1097/RCT.0000000000000262.
  4. Kogler AS, Bilfinger TV, Galler RM, Mesquita RC, Cutrone M, Schenkel SS, Yodh AG, Floyd TF. Fiber-optic Monitoring of Spinal Cord Hemodynamics in Experimental Aortic Occlusion. Anesthesiology. 2015 Dec;123(6):1362-73.
  5. Monastiriotis S, Gonzales C, Kokkosis A, Labropoulos N, Bilfinger T, Tassiopoulos AK. The Use of AngioVac for Symptomatic Aortic Thrombus Complicated by Mesenteric Ischemia. Ann Vasc Surg. 2016 Apr;32:129.e1- 6. doi: 10.1016/j.avsg.2015.09.026. Epub 2016 Jan 22.

Dr. Michelle Bloom

  1. Hamo CE, Bloom MW. Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy. Clin Med Insights Cardiol. 2015 Aug 2;9(Suppl 2):47-51. doi: 10.4137/CMC.S19704. eCollection 2015. Review.
  2. Szema A, McLarty A, Skopicki H, Bloom M, Jermyn R. Heart Failure: An Exploration of Recent Advances in Research and Treatment (A). Clin Med Insights Cardiol. 2015 Oct 4;9(Suppl 2):53-6. doi: 10.4137/CMC.S32652. eCollection 2015.
  3. Bloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, Skopicki H, Lenihan DJ, Gheorghiade M, Lyon AR, Butler J. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging. Circ Heart Fail. 2016 Jan;9(1):e002661. doi: 10.1161/CIRCHEARTFAILURE.115.002661. Review.
  4. Hamo CE, Bloom MW, Cardinale D, Ky B, Nohria A, Baer L, Skopicki H, Lenihan DJ, Gheorghiade M, Lyon AR, Butler J. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions. Circ Heart Fail. 2016 Feb;9(2):e002843. doi: 10.1161/CIRCHEARTFAILURE.115.002843. Review.
  5. Moin DS, Bloom MW, Papadimitriou L, Butler J. Serelaxin for the treatment of heart failure. Expert Rev Cardiovasc Ther. 2016 Jun;14(6):667-75. doi: 10.1586/14779072.2016.1174067. Epub 2016 Apr 26.

Dr. Javed Butler

  1. Vaduganathan M, Butler J, Pitt B, Gheorghiade M. Contemporary Drug Development in Heart Failure. A Call for Hemodynamically Neutral Therapies. Circ irc Heart Fail. 2015; July 2015; 8:4 826-831.
  2. Golwala H, Pandey A, Ju C, Butler J, Yancy C, Bhatt D, Hernandez A, Fonarow GC. Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines–Heart Failure Registry. J Am Coll Cardiol. 2015;66(8):917-926.
  3. Wilcox JE, Fonarow GC, Bonow RO, Butler J, Sauer AJ, Epstein SE, Khan SS, Kim RJ, Sabbah HN, Diez, J, Gheorghiade M. Targeting the Heart in Heart Failure: Myocardial Recovery in Patients with Heart Failure and Systolic Dysfunction. JACC Heart Fail. 2015 Sep;3(9):661-9. doi: 10.1016/j.jchf.2015.04.011.
  4. Vaduganathan M, Marti CN, Mentz RJ, Greene SJ, Ambrosy AP, Subacius HP, Fonarow GC, Chioncel O, Bazari H, Maggioni AP, Zannad F, Konstam MA, Sato N, Gheorghiade M, Butler J; on behalf of the EVEREST trial investigators. Serum Osmolality and Post-Discharge Outcomes after Heart Failure Hospitalization: Insights from the EVEREST Trial. Am J Cardiol. 2016 Jan 14.
  5. Butler J, Gheorghiade M, Kelkar AA, Fonarow GC, Anker S, Greene SJ, Papadimitriou L, Collins S, Ruschitzka F, Yancy CW, Teerlink JR, Adams K, Cotter G, Ponikowski P, Felker GF, Metra M, Filippatos G. In-Hospital Worsening Heart Failure. Eur J Heart Fail. 2015 Nov;17(11):1104-13.
  6. Brown K; Chee J, Kyung S, Vettichira B, Papadimitriou L, Butler J. Mineralocorticoid Receptor Antagonism in Acute Heart Failure. Curr Treat Options Cardiovasc Med. 2015 Sep;17(9):402.
  7. Wilcox JE, Fonarow GC, Ardehali, H, Bonow RO, Butler J, Sauer AJ, Epstein SE, Khan SS, Kim RJ, Sabbah HN, Díez J, Gheorghiade G. Targeting the Heart’ in Heart Failure: Myocardial Recovery in Heart Failure with Reduced Ejection Fraction. JACC Heart Fail. 2015 Sep;3(9):661-9.
  8. Ahmed A, Patel K, Fonarow GC, Morgan C, Butler J, Bittner V, Kulczycki A, Kheirbek R, Aronow W, Fletcher R, Brown C, Ahmed A. Higher risk for incident heart failure and cardiovascular mortality among community-dwelling octogenarians without pneumococcal vaccination. Accepted in European Society of Cardiology Heart Failure. Article first published online: 21 SEP 2015, DOI: 10.1002/ehf2.12056.
  9. Kelkar A, Butler J, Schelbert EB, Greene SJ, Quyyumi AA, Bonow RO, Cohen R, Gheorghiade M, Lipinski MJ, Sun W, Luger D, Epstein SE. Mechanisms Contributing to Progression of Ischemic and Nonischemic Dilated Cardiomyopathy and the Possible Role of Stem Cell Therapy. J Am Coll Cardiol. 2015 Nov 3;66(18):2038-47.
  10. Echouffo-Tcheugui JB, Butler J, Yancy CW, Fonarow GC. Association of Physical Activity or Fitness with Incident Heart Failure: A Systematic Review and Meta-analysis. Circulation: Heart Failure. Circ Heart Fail. 2015 Sep;8(5):853-61.
  11. Kalogeropoulos A, Al-Anbari R, Pekarek A, Wittersheim K, Pernetz MA, Hampton A, Steinberg J, Georgiopoulou V, Butler J, Vega JD, Smith AL. The Right Ventricular Function after Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary results. Eur Heart J Cardiovasc Imaging. 2015 Jul 9.
  12. Papadimitriou L, Georgiopoulou VV, Kort S, Butler J, Kalogeropoulos A. Echocardiography in Acute Heart Failure: Current Perspectives. J Card Fail. 2015 Aug 12. pii: S1071-9164(15)00667-3.
  13. Senni M, Gavazzi A, Gheorghiade M, Butler J. Heart Failure at Crossroads. Moving Beyond Blaming Stakeholders to Targeting the Heart. Eur J Heart Fail. 2015 Aug;17(8):760-3.
  14. Ambrosy AP, Hernandez AF, Armstrong PW, Butler J, Califf RM, Dunning A, Ezekowitz JA, Felker GM, Greene SJ, Kaul P, McMurray JJ, Metra M, Connor CM, Reed SD, Schulte P, Starling RC, Tang WHW, Voors AA, Mentz RJ. The Clinical Course of Health Status and Association with Outcomes in Patients Hospitalized for Heart Failure - Insights from ASCEND-HF. Eur J Heart Fail. 2015 Oct 14. doi: 10.1002/ejhf.420.
  15. Morris AA, Pekarek A, Wittersheim K, Cole RT, Gupta D, Nguyen D, Laskar SR, Butler J, Smith AL, Vega JD. Gender differences in risk of stroke during support with continuous flow left ventricular assist device (LVAD). J Heart Lung Transplant. 2015 Sep 3. pii: S1053-2498(15)01388-1. doi: 10.1016/j.healun.
  16. Clements IP, Kelkar A, Garcia EV, Butler J, Chen J, Folks R, Jacobson AF. Prognostic Significance 123I-mIBG SPECT Myocardial Imaging in Heart Failure. Differences Between Ischemic and Non-ischemic Heart Failure. Eur Heart J Cardiovasc Imaging. 2015 Nov 20. pii: jev295. [Epub ahead of print]
  17. Ferreira JP, Girerd N, Medeiros PB, Santos M, Carvalho HC, Bettencourt P, Kénizou D, Butler J, Zannad F, Rossignol P. Spot Urine Sodium Excretion as Prognostic Marker in Acutely Decompensated Heart Failure: The Spironolactone Effect. Clin Res Cardiol. 2015 Nov 28. [Epub ahead of print]
  18. Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP, Ponikowski P, Shah SJ, Solomon SD, Kraigher-Krainer E, Samano ET, Müller K, Roessig L, Pieske B; SOCRATES-REDUCED Investigators and Coordinators. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial. JAMA. 2015 Dec 1;314(21):2251-2262. doi: 10.1001/jama.2015.15734.
  19. D’Elia E, Vaduganathan M, Gori M, Gavazzi A, Butler J, Senni M. Role of Biomarkers in Cardiac Structure Phenotyping Heart Failure with Preserved Ejection Fraction: ritical appraisal and practical use. Eur J Heart Fail. 2015 Oct 23. doi: 10.1002/ejhf.430. [Epub ahead of print]
  20. Vaduganathan M, Goldsmith SR, Butler J, Gheorghiade M. Contrasting Acute and Chronic Effects of Tolvaptan on Serum Osmolality: Relationship to Outcomes inthe EVEREST Trial. Eur J Heart Fail. 2015 Oct 7. doi: 10.1002/ejhf.415. [Epub ahead of print]
  21. Grodin JL, Perez A, Wu Y, Hernandez AF, Butler J, Metra M, Felker GM, Voors AA, McMurray JJ, Armstrong PW, Califf RM, Starling RC, O'Connor CM, Tang W. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights from the ASCEND-HF Trial. JACC Heart Fail. 2015 Oct;3(10):777-85.
  22. Miller CR, Butler J, Culler SD, Gary RA, Higgins M, Schindler P, Butts B, Dunbar SB. An Economic Evaluation of a Self-Care Intervention in Persons with Heart Failure and Diabetes. J Card Fail. 2015 Sep;21(9):730-7.
  23. Smith SA, Mentz RJ, Roessig L, Mebazza A, Longrois D, Gheorghiade M, Pitt B, Zannad F, Butler J, Abraham WT. Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials. Am J Cardiol. 2015 Oct 15;116(8):1304-10.
  24. Paterna S, di Gaudio F, La Rocca V, Balistreri F, Greco M, Torres D, Lupo U, Rizzo G, di Pasquale P, Indelicato S, Butler J, Parrinello G. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure. Adv Ther. 2015 Oct;32(10):971-82. doi: 10.1007/s12325-015-0254-9. Epub 2015 Oct 31.
  25. D’Elia E, Vaduganathan M, Gori M, Gavazzi A, Butler J, Senni M.The Role of Biomarkers in Phenotyping Heart Failure with Preserved Ejection Fraction: Critical Appraisal and Practical Use. Eur J Heart Fail. 2015 Oct 23. doi: 10.1002/ejhf.430. [Epub ahead of print]
  26. McCabe NC, Dunbar SB, Butler J, Higgins M, Book W, Reilly C. Antecedents of Self-Care in Adults with Congenital Heart Defects. Int J Cardiol. 2015 Dec 15;201:610-5. doi: 10.1016/j.ijcard.2015.08.125. Epub 2015 Aug 16.
  27. Khan SS, Butler J, Subacius H, Gheorghiade M. Reply: Are Changes in Serum Potassium Levels During Admissions for Acute Decompensated Heart Failure Irrelevant for Prognosis: The End of the Story? Am J Cardiol. 2015 Sep 1;116(5):825-6.
  28. Hammadah M, Georgiopoulou VV, Kalogeropoulos AP, Weber M, Wang X, Samara MA, Gul Z, Wu Y, Hazen SL, Butler J, Tang WHW. Elevated soluble Fms-like tyrosine kinase 1 and placental-like growth factor levels are associated with development and mortality risk in heart failure. Circ Heart Fail. 2016 Jan;9(1):e002115. doi: 10.1161/CIRCHEARTFAILURE.115.002115. Epub 2015 Dec 23.
  29. Greenberg B, Butler J, Felker GM, Ponikowski P, Voors AA, Pogoda JM, Provos R, Guerrero J, Hajjar RJ, Zsebo KM. Prevalence of AAV1 Neutralizing Antibodies and Consequences for a Clinical Trial of Gene Transfer for Advanced Heart Failure. Gene Ther. 2015 Dec 24. doi: 10.1038/gt.2015.109. [Epub ahead of print]
  30. Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR, Valeti US, Chang CCH, Shroff SG, Diez J, Miller CA, Schmitt M, Kellman P, Butler J, Gheorghiade M. Wong TC. Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc. 2015 Dec 18;4(12).
  31. Samsky M, Teerlink JR; Armstrong PW, Starling RC, TANG Wh, Ezekowitz JA, Metra M, Voors AA, McMurray JVJj, O'Connor CM, Butler J, Mentz RJ, DeVore A, Hernandez A, Patel C, Regnier Y. Liver Function tests in patients wth acute heart failure and associated outcomes: Insights from ACSEND-HF. Eur J Heart Fail. 2015 Dec 28. doi: 10.1002/ejhf.440. [Epub ahead of print]
  32. Butler J, Tahhan AS, Georgiopoulou V, Kelkar A, Lee M, Khan B, Peterson E, Fonarow GC, Kalogeropoulos AP, Gheorghiade M. Trends in Characteristics of Cardiovascular Clinical Trials 2001-2012. Am Heart J. 2015 Aug;170(2):263-72.
  33. Reilly CM, Butler J, Culler Gary RA, Higgins M, Schindler P, Dunbar SB. An Economic Evaluation of a Self-Care Intervention in Persons with Heart Failure and Diabetes. J Card Fail. 2015 Sep;21(9):730-7.
  34. Donahey EE, Polly DM, Vega JD, Lyon M, Butler J, Nguyen D, Pekarek A, Wittersheim K, Kilgo P, Paciullo C. Multidrug Resistant Organism Infections In Patients With Left Ventricular Assist Devices. Tex Heart Inst J. 2015 Dec 1;42(6):522-7.
  35. Butts B, Gary RA, Dunbar SB, Butler J. Methylation of Apoptosis-Associated Speck-Like Protein With a Caspase Recruitment Domain and Outcomes in Heart Failure. J Card Fail. 2015 Dec 14. pii: S1071-9164(15)01213-0. doi: 10.1016/j.cardfail.2015.12.004. [Epub ahead of print]
  36. Grodin JL, Stevens SR, De las Fuentes L, Kiernan M, Birati EY, Gupta D, Bart BA, Felker GM, Chen HH, Butler J, Dávila-Román VG, Margulies KB, Hernandez A, Anstrom K, Tang WH. Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. J Card Fail. 2016 Jan;22(1):26-32.
  37. Patel N, Macon C, Ju C, Thadani U, Schulte PJ, Hernandez AF, Bhatt DL, Butler J, Yancy CW, Fonarow CG. Temporal Trends of Digoxin Use in Patients Hospitalized with Heart Failure: Analysis from the American Heart Association Get With The Guidelines-Heart Failure Registry. JACC Heart Fail. 2016 May;4(5):348-56.
  38. Vaduganathan M, Michel A, Hall K, Mulligan C, Shah SJ, Senni M, Triggiani M, Butler J, Gheorghiade M. Spectrum of Epidemiologic and Clinical Findings in Patients with Heart Failure with Preserved Ejection Fraction Stratified by Study Design: A Systematic Review. Eur J Heart Fail. 2016 Jan;18(1):54-65.
  39. Greene SJ, Temporelli PL; Campia U, Vaduganathan M, Esposti LD, Buda S, Veronesi C, Butler J; Nodari S. Effects of Polyunsaturated Fatty Acid Treatment on Post-discharge Outcomes After Acute Myocardial Infarction. Am J Cardiol. 2016 Feb 1;117(3):340-6.
  40. Bloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, Skopicki H, Lenihan DJ, Gheorghiade M, Lyon AR, Butler J. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure. Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging. Circ Heart Fail. 2016 Jan;9(1):e002661.
  41. Chioncel O, Collins SP, Greene SJ, Ambrosy AP, Vaduganathan M, Macarie C, Butler J, Gheorghiade M. Natriuretic peptide-guided management in heart failure. J Cardiovasc Med (Hagerstown). J Cardiovasc Med (Hagerstown). 2016 Apr 22. [Epub ahead of print]
  42. Hamo CE, Bloom MW, Cardinale D, Ky B, Nohria A, Baer L, Skopicki H, Lenihan DJ, Gheorghiade M, Lyon AR, Butler J. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure. Part 2: Prevention, Treatment, Guidelines, and Future Directions. Circ Heart Fail. 2016 Feb;9(2):e002843.
  43. Sudden Cardiac Death in Heart Failure with Preserved Ejection Fraction: A Target for Therapy? Vaduganathan V, Patel RB, Shah SJ, Butler J. Heart Fail Rev. 2016 Jan 13. [Epub ahead of print]
  44. Cook TD, Greene SJ, Kalogeropoulos AP, Fonarow GC, Zea R, Swedberg K, Zannad F, Maggioni AP, Konstam MA, Gheorghiade M, Butler J. Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the Everest Trial). Am J Cardiol. 2016 Feb 15;117(4):611-6.
  45. Greenberg B, Butler J, Felker GM, Ponikowski P, Voors AA, Desai AS, Barnard D, Bouchard A, Jaski B, Lyon AR, Pogoda JM, Rudy JJ, Zsebo KM. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet. 2016 Jan 21. pii: S0140-6736.
  46. Gencer B, Auer R, de Rekeneire N, Butler J, Kalogeropoulos A, Bauer DC, Kritchevsky SB, Miljkovic I, Vittinghoff E, Harris T, Rodondi N. Association between resistin levels and cardiovascular disease events in older adults: The health, aging and body composition study. Atherosclerosis. 2016 Feb;245:181-6. doi: 10.1016.
  47. Cook TD, Greene SJ, Kalogeropoulos AP, Fonarow GC, Zea R, Swedberg K, Zannad F, Maggioni AP, Konstam MA, Gheorghiade M, Butler J. Temporal Changes in Post-Discharge Mortality Risk Following Hospitalization for Heart Failure (from the EVEREST Trial). Am J Cardiol. 2016 Feb 15;117(4):611-6.
  48. Greene SJ, Sabbah HN, Butler J, Voors AA, Albrecht-Küpper BE, Düngen HD, Dinh W, Gheorghiade M. Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure. Heart Fail Rev. 2016 Jan;21(1):95-102. doi: 10.1007/s10741-015-9522-7.
  49. Sharma A, Fonarow GC, Butler J, Ezekowitz JA, Felker GM. Coenzyme Q10 in the treatment of heart failure: A State-of-the-Art Review. Circ Heart Fail. 2016 Apr;9(4).
  50. Hamo CE, Butler J. How to Best Identify Elderly Individuals Who May Develop Heart Failure. Curr Cardiovasc Risk Rep (2016) 10:19 DOI 10.1007/s12170-016-0500-y
  51. Papadimitriou L, Smith-Jones P, Sarwar C, Norton C, Skopicki H, Yaddanapudi K, Gheorghiade M, Parsey R, Butler J. Utility of Positron Emission Tomography For Drug Development for Heart Failure. Am Heart J. 2016 May;175:142-52.
  52. Butler J, M. Metra, M. Gheorghiade. Moving Away From Symptoms Based Heart Failure Treatment Misperceptions And Real Risks For Patients With Heart Failure. Eur J Heart Fail. 2016 Mar 17. doi: 10.1002/ejhf.507. [Epub ahead of print]
  53. Mecklai A, Subačius H, Konsta MA, Gheorghiade M, Butler J, Katz SD. In-Hospital Diuretic Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure. Insights from the EVEREST Trial. JACC Heart Fail. 2016 Mar 25. pii: S2213-1779(16)00104-9. doi: 10.1016/j.jchf.2016.02.008. [Epub ahead of print]
  54. Magnani JW, Wang N, Benjamin EJ, Garcia ME, Bauer D, Butler J, Ellinor PT, Kritchevsky S, Marcus GM, Newman A, Phillips CL, Sasai H, Satterfield S, Sullivan LM, Harris TB; for the Health, Aging, and Body Composition Study. Atrial Fibrillation and Declining Physical Function in Older Adults: the Health, Aging and Body Composition Study (Health ABC). Circ Arrhythm Electrophysiol. 2016 May;9(5).
  55. Bjork BJ, Alton KK, Georgiopoulou VV, Butler J, Kalogeropoulos AP. Defining Defining Advanced Heart Failure: A Systematic Review of Criteria Used in Clinical Trials. J Card Fail. 2016 Mar 11. pii: S1071-9164(16)00076-2. doi: 0.1016/j.cardfail.2016.03.003. [Epub ahead of print]
  56. Moin DS, Bloom MW, Papadimitriou L, Butler J. Serelaxin for the treatment of heart failure. Expert Rev Cardiovasc Ther. 2016 Jun;14(6):667-75.
  57. Kelkar AA, Spertus J, Pang P, Pierson RF, Cody RJ, Pina IL, Hernandez A, Butler J. Utility of Patient-Reported Outcome Instruments in Heart Failure. JACC Heart Fail. 2016 Mar;4(3):165-75. doi: 10.1016/j.jchf.2015.10.015. Epub 2016 Feb 10.
  58. Giamouzis G, Schelbert EB, Butler J. Growing Evidence Linking Microvascular Dysfunction With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2016 Feb 23;5(2).
  59. Gheorghiade M, Larson CJ, Shah SJ, Greene SJ, Cleland JGF, Colucci WS, Dunnmon P, Epstein SE, Kim RJ, Parsey RV, Stockbridge N, Carr J, Dinh W, Krahn T, Kramer F, Wahlander K, Deckelbaum LI, Crandall D, Okada S, Senni M, Sikora S, Sabbah H, Butler J. Developing New Treatments for Heart Failure: Focus on the Heart. Circ Heart Fail. 2016 May;9(5).
  60. Smith JG, Felix JF, Morrison AC, Kalogeropoulos A, Trompet S, Wilk JB, Gidlöf O, Wang X, Morley M, Mendelson M, Joehanes R, Ligthart S, Shan X, Bis JC, Wang YA, Sjögren M, Ngwa J, Brandimarto J, Stott DJ, Aguilar D, Rice KM, Sesso HD, Demissie S, Buckley BM, Taylor KD, Ford I, Yao C, Liu C; CHARGE-SCD consortium; EchoGen consortium; QT-IGC consortium; CHARGE-QRS consortium, Sotoodehnia N, van der Harst P, Stricker BH, Kritchevsky SB, Liu Y, Gaziano JM, Hofman A, Moravec CS, Uitterlinden AG, Kellis M, van Meurs JB, Margulies KB, Dehghan A, Levy D, Olde B, Psaty BM, Cupples LA, Jukema JW, Djousse L, Franco OH, Boerwinkle E, Boyer LA, Newton-Cheh C, Butler J, Vasan RS, Cappola TP, Smith NL. Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure. PLoS Genet. 2016 May 5;12(5):e1006034. doi: 10.1371/journal.pgen.1006034. eCollection 2016 May.
  61. Patel R, Vaduganathan M, Samman-Tahhan A, Kalogeropoulos A, Georgiopoulou V, Fonarow G, Gheorghiade M, Butler J. Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials: A Systematic Review. Am J Cardiol. 2016 Jun 1;117(11):1845-50.
  62. Muthiah Vaduganathan, Patel RV, Samman-Tahhan A, Kalogeropoulos AP, Georgiopoulou VV, Fonarow GC, Gheorghiade M, Butler J. Cardiovascular Clinical Trials with Noninferiority or Equivalence Designs from 2001 to 2012. Int J Cardiol. 2016 Jul 1;214:16-8.
  63. Ambrosy AP, Khan H, Mentz RJ, Chioncel O, Greene SJ, Vaduganathan M, Konstam MA, Swedberg K, Zannad F, Maggioni AP, Gheorghiade M, Butler J. Changes in Dyspnea Status During Hospitalization and Post-Discharge Health-Related Quality of Life in Hospitalized Heart Failure Patients. Findings from the EVEREST Trial. Circ Heart Fail. 2016 May;9(5).
  64. Vaduganathan M, Pallais JC, Fenves AZ, Butler J, Gheorghiade M. Serum chloride in heart failure: a salty prognosis. Eur J Heart Fail. 2016 Apr 27.
  65. Kunutsor SK, Laukkanen JA, Bluemke DA, Butler J, Khan H. Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: Prospective study and pooled analysis of published evidence. Eur J Prev Cardiol. 2016 Apr 15.
  66. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C.. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016 May 17. pii: S0735-1097(16)33024-8. doi: 10.1016/j.jacc.2016.05.011.
  67. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016 May 20. pii: CIR.0000000000000435.
  68. Georgiopoulou V, Tang WH, Giamouzis G, Li S, Deka A, Dunbar S, Butler J, Kalogeropoulos A. Renal Biomarkers and Outcomes in Outpatients with Heart Failure: The Atlanta Cardiomyopathy Consortium. Int J Cardiol. 2016 May 13;218:136-143.
  69. Kapoor JR, Kapoor R, Ju C, Heidenreich PA, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC. Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized with Heart Failure with Reduced, Borderline and Preserved Ejection Fraction. JACC: Heart Failure, Volume 4, Issue 6, June 2016, Pages 464–472.
  70. Tang W, Wu Y, Grodin JL, Hsu AP, Hernandez AF, Butler J, Metra M, Voors AA, Felker GM, Troughton RW, Mills RM, McMurray JJ, Armstrong PW, Califf RM, O'Connor CM, Starling RC. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. JACC Heart Fail. 2016 Jan;4(1):68-77.
  71. Collins SP, Levy PD, Martindale JL, Dunlap ME, Storrow AB, Pang PS, Albert NM, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hollander JE, Lanfear DJ, Lenihan DJ, Lindenfeld JM, Frank Peacock W, Sawyer DB, Teerlink JR, Butler J. Clinical and Research Considerations for Patients with Hypertensive Acute Heart Failure A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group. Acad Emerg Med. 2016 Jun 10.
  72. Kerkhoff LA, Butler J, Kelkar AA, Shore S, Speight CD, Wall LK, Dickert NW.Trends in Consent for Clinical Trials in Cardiovascular Disease.J Am Heart Assoc. 2016 Jun 17;5(6).
  73. Sanam K, Bhatia V, Bajaj N, Gaba S, Morgan CJ, Fonarow G, Butler J, Deedwania P, Prabhu S, Wu WC, White M, Love T, Aronow W, Fletcher RS, Allman A. Renin-Angiotensin System Inhibition and Lower 30-day All-cause Readmission in Medicare Beneficiaries with Heart Failure. Am J Med. 2016 Jun 1. pii: S0002-9343(16)30541-1.
  74. Arundel C, Lam P, Khosla R, Blackman MR, Fonarow GC, Morgan C, Zeng Q, Fletcher RD, Butler J, Wu WC, Deedwania P, Love TE, White M, Aronow WS, Anker SD, Allman RM, Ahmed A. Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure. Am J Med. 2016 Jul 8. pii: S0002-9343(16)30675-1. doi: 10.1016/j.amjmed.2016.06.018. [Epub ahead of print]
  75. Bhatt KN, Kalogeropoulos AP, Dunbar SB, Butler J, Georgiopoulou VV. Depression in heart failure: Can PHQ-9 help?Int J Cardiol. 2016 Jul 5;221:246-250. doi: 10.1016/j.ijcard.2016.07.057. [Epub ahead of print]
  76. Ahmed A, Sanam K, Bhatia V, Bajaj N, Gaba S, Morgan C, Fonarow GC, Butler J, Deedwania P.Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Hospitalized Medicare Beneficiaries with Heart Failure and Reduced Ejection Fraction. Am J Med. 2016 Jun 2. pii: S0002-9343(16)30541-1.
  77. Kalogeropoulos AP, Fonarow GC, Georgiopoulou V, Burkman G, Siwamogsatham S, Patel A, Li S, Papadimitriou L, Butler J. Heart Failure with Recovered Versus Preserved Ejection Fraction in Outpatients: Characteristics and Outcomes. JAMA Cardiol. 2016 Jul 6. doi: 10.1001/jamacardio.2016.1325.
  78. Zannad F, Rossignol P, Stough WG, Epstein M, Alonso A, Bakris GL, Butler J, Kosiborod M, Berman L, Mebazaa A,Rasmussen HS, Ruilope LM, Stockbridge N, Thompson A, Wittes J, Pitt B. New Drugs for Managing Hyperkalemia in Patients Receiving Renin Angiotensin Aldosterone Inhibitor Therapy: Considerations for Clinical Trial Design and Regulatory Approval. Int J Cardiol. 2016 Aug 1;216:46-51.
  79. Kerkhoff LA, Butler J, Kelkar AA, Shore S, Speight CD, Wall LK, Dickert NW.Trends in Consent for Clinical Trials in Cardiovascular Disease.J Am Heart Assoc. 2016 Jun 17;5(6).
  80. Sanam K, Bhatia V, Bajaj N, Gaba S, Morgan CJ, Fonarow G, Butler J, Deedwania P, Prabhu S, Wu WC, White M, Love T, Aronow W, Fletcher RS, Allman A. Renin-Angiotensin System Inhibition and Lower 30-day All-cause Readmission in Medicare Beneficiaries with Heart Failure. Am J Med. 2016 Jun 1. pii: S0002-9343(16)30541-1.
  81. Arundel C, Lam P, Khosla R, Blackman MR, Fonarow GC, Morgan C, Zeng Q, Fletcher RD, Butler J, Wu WC, Deedwania P, Love TE, White M, Aronow WS, Anker SD, Allman RM, Ahmed A. Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure. Am J Med. 2016 Jul 8. pii: S0002-9343(16)30675-1. doi: 10.1016/j.amjmed.2016.06.018. [Epub ahead of print]
  82. Bhatt KN, Kalogeropoulos AP, Dunbar SB, Butler J, Georgiopoulou VV. Depression in heart failure: Can PHQ-9 help?Int J Cardiol. 2016 Jul 5;221:246-250. doi: 10.1016/j.ijcard.2016.07.057. [Epub ahead of print]
  83. Collins SP, Levy PD, Martindale JL, Dunlap ME, Storrow AB, Pang PS, Albert NM, Felker GM, Fermann GJ, Fonarow GC, Givertz MM, Hollander JE, Lanfear DJ, Lenihan DJ, Lindenfeld JM, Frank Peacock W, Sawyer DB, Teerlink JR, Butler J. Clinical and Research Considerations for Patients with Hypertensive Acute Heart Failure A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group. Journal of Cardiac Failure Volume 22, Issue 8, August 2016, Pages 618–627.
  84. Adams KF, Butler J, Patterson JH, Gattis Stough W, Bauman JL, van Veldhuisen DJ, Schwartz TA, Sabbah HN, Mackowiak JI, Ventura HO, Ghali JK. Dose Response Characterization of the Association of Serum Digoxin Concentration with Mortality Outcomes in the Digitalis Investigation Group Trial. Eur J Heart Fail. 2016 Aug;18(8):1072-81.
  85. Butler J, Hernandez AF, Anstrom KJ, Kalogeropoulos A, Redfield MM, Konstam MA, Tang WH, Felker GM, Shah MR, Braunwald E. Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. JACC Heart Fail. 2016 Jul 30.
  86. Braun LT, Grady KL, Kutner JS, Adler E, Berlinger N, Boss R, Butler J, Enguidanos S, Friebert S, Gardner TJ, Higgins P, Holloway R, Konig M, Meier D, Morrissey MB, Quest TE, Wiegand DL, Coombs-Lee B, Fitchett G, Gupta C, Roach WH Jr. Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke AssociationAmerican Heart Association Advocacy Coordinating Committee. Circulation. 2016 Aug 8.
  87. Greene SJ, Hernandez AF, Sun JL, Metra M, Butler J, Ambrosy AA, Ezekowitz JA, Starling RC, Teerlink JR, Schulte PJ, Voors AA, Amstrong PW, O’Connor CM, Mentz RJ. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and Endpoints: Insights from the ASCEND-HF Trial. Accepted in Circulation Heart Failure.
  88. Triposkiadis F, Pieske B, Butler J, Parissis J, Giamouzis G, Skoularigis J, Brutsaert D, Boudoulas H. Global Left Atrial Dysfunction in Heart Failure. Accepted in Eurpopean Journal of Heart Failure.
  89. Echouffo-Tcheugui JB, Xu H, DeVore AD, Schulte P, Butler J, Yancy CW, Bhatt D, Hernandez AF, Heidenreich AP, Fonarow GC. Temporal Trends and Factors Associated With Diabetes Mellitus Among Patients Hospitalized With Heart Failure - Findings From Get With The Guidelines–Heart Failure Registry. Accepted in American Heart Journal.
  90. Hammadah M. W. Tang, Butler J, Kalogeropoulos A, Georgiopoulou V, Yuping W, Hazen S. High-density Lipoprotein Associated Paraoxonase-1 Activity for Prediction of Adverse Outcomes in Outpatients with Chronic Heart Failure. Accepted in the European Journal of Heart Failure

>> Back to Top

Dr. Joanna Chikwe

  1. Chikwe J. Invited Commentary. Ann Thorac Surg. 2015 Sep;100(3):873-4. doi: 10.1016/j.athoracsur.2015.04.002.
  2. Honikman R, Chikwe J, Tokita JE, Mittnacht AJ.Needle Migration to the Heart: An Unusual Association of Hemodialysis and Cardiovascular Morbidity. A A Case Rep. 2015 Oct 15;5(8):131-3. doi: 10.1213/XAA.0000000000000193.
  3. Chatterjee S, Tripathi B, Virk HU, Ahmed M, Bavishi C, Krishnamoorthy P, Sardar P, Giri J, Omidvari K, Chikwe J. Does Surgical Repair of Moderate Ischemic Mitral Regurgitation Improve Survival? A Systematic Review. Curr Cardiol Rep. 2016 Mar;18(3):22. doi: 10.1007/s11886-016-0701-5.
  4. Anyanwu AC, Itagaki S, Chikwe J, El-Eshmawi A, Adams DH. A complexity scoring system for degenerative mitral valve repair. J Thorac Cardiovasc Surg. 2016 Jun;151(6):1661-70. doi: 10.1016/j.jtcvs.2016.01.033. Epub 2016 Jan 22.
  5. Chikwe J. Niche generation. J Thorac Cardiovasc Surg. 2016 Mar;151(3):640-1.

>> Back to Top

Dr. Roger Fan

  1. Cabrera S, Vallès E, Benito B, Alcalde Ó, Jiménez J, Fan R, Martí-Almor J. Simple predictors for new onset atrial fibrillation. Int J Cardiol. 2016 Jul 8;221:515-520. doi: 10.1016/j.ijcard.2016.07.077. [Epub ahead of print]

>> Back to Top

Dr. Luis Gruberg

  1. Weisz G, Généreux P, Iñiguez A, Zurakowski A, Shechter M, Alexander KP, Dressler O, Osmukhina A, James S, Ohman EM, Ben-Yehuda O, Farzaneh-Far R, Stone GW; RIVER-PCI investigators. Collaborators : L. Gruberg. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2016 Jan 9;387(10014):136-45. doi: 10.1016/S0140-6736(15)00459-6. Epub 2015 Oct 22.
  2. Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW; ABSORB III Investigators. Collaborators : L. Gruberg Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. N Engl J Med. 2015 Nov 12;373(20):1905-15. doi: 10.1056/NEJMoa1509038. Epub 2015 Oct 12.
  3. Gruberg L, Hellkamp AS, Thomas LE, de Lemos JA, Scirica BM, Hilliard A, Enriquez JR, Mohsen A, Wang TY.The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2015 Dec 28;8(15):1954-62. doi: 10.1016/j.jcin.2015.08.030.
  4. O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA, Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA; LATITUDE-TIMI 60 Investigators. Collaborators : L. Gruberg. Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial. JAMA. 2016 Apr 19;315(15):1591-9.
  5. Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L; DAPT Study Investigators. Collaborators : L. Gruberg. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016 Apr 26;315(16):1735-49. doi: 10.1001/jama.2016.3775. Erratum in: JAMA. 2016 Jul 19;316(3):350.

>> Back to Top

Dr. Anne Hamik

  1. Hale AT, Longenecker CT, Jiang Y, Debanne SM, Labatto DE, Storer N, Hamik A, McComsey GA. HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4. AIDS. 2015 Aug 24;29(13):1643-50. doi: 10.1097/QAD.0000000000000756.
  2. Mehanna E, Hamik A, Josephson RA. Cardiorespiratory Fitness and Atherosclerosis: Recent Data and Future Directions. Curr Atheroscler Rep. 2016 May;18(5):26. doi: 10.1007/s11883-016-0580-7. Review.

>> Back to Top

Dr. Allen Jeremias

  1. Solomon R, Gordon P, Manoukian SV, Abbott JD, Kereiakes DJ, Jeremias A, Kim M, Dauerman HL; BOSS Trial Investigators.Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD. Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1519-24. doi: 10.2215/CJN.05370514. Epub 2015 Jul 16.
  2. Johnson NP, Jeremias A, Zimmermann FM, Adjedj J, Witt N, Hennigan B, Koo BK, Maehara A, Matsumura M, Barbato E, Esposito G, Trimarco B, Rioufol G, Park SJ, Yang HM, Baptista SB, Chrysant GS, Leone AM, Berry C, De Bruyne B, Gould KL, Kirkeeide RL, Oldroyd KG, Pijls NH, Fearon WF. Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment. JACC Cardiovasc Interv. 2016 Apr 25;9(8):757-67. doi: 10.1016/j.jcin.2015.12.273.
  3. Mallidi J, Atreya AR, Cook J, Garb J, Jeremias A, Klein LW, Lotfi A.Long-term outcomes following fractional flow reserve-guided treatment of angiographically ambiguous left main coronary artery disease: A meta-analysis of prospective cohort studies. Catheter Cardiovasc Interv. 2015 Jul;86(1):12-8. doi: 10.1002/ccd.25894.
  4. Toth GG, Johnson NP, Jeremias A, Pellicano M, Vranckx P, Fearon WF, Barbato E, Kern MJ, Pijls NH, De Bruyne B.Standardization of Fractional Flow Reserve Measurements. J Am Coll Cardiol. 2016 Aug 16;68(7):742-53.

>> Back to Top

Dr. Smadar Kort

  1. Papadimitriou L, Georgiopoulou VV, Kort S, Butler J, Kalogeropoulos AP. Echocardiography in Acute Heart Failure: Current Perspectives. J Card Fail. 2016 Jan;22(1):82-94.

>> Back to Top

Dr. Allison J. McLarty

  1. Szema A, McLarty A, Skopicki H, Bloom M, Jermyn R. Heart Failure: An Exploration of Recent Advances in Research and Treatment (A). Clin Med Insights Cardiol. 2015 Oct 4;9(Suppl 2):53-6. doi: 10.4137/CMC.S32652. eCollection 2015.

>> Back to Top

Dr. Puja Parikh

  1. Koutrolou-Sotiropoulou P, Parikh PB, Miller C, Lima FV, Butler J, Stergiopoulos K.Impact of Heart Disease on Maternal and Fetal Outcomes in Pregnant Women. Am J Cardiol. 2015 Aug 1;116(3):474-80. doi: 10.1016/j.amjcard.2015.04.063. Epub 2015 May 9.
  2. Kirtane AJ, Parikh PB, Stuckey TD, Xu K, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Parvataneni R, Maehara A, Généreux P, Mehran R, Stone. Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). GW. JACC Cardiovasc Interv. 2015 Dec 28;8(15):1978-87. doi: 10.1016/j.jcin.2015.08.032
  3. Patel JK, Parikh PB. Association between therapeutic hypothermia and long-term quality of life in survivors of cardiac arrest: A systematic review. Resuscitation. 2016 Jun;103:54-9. doi: 10.1016/j.resuscitation.2016.03.024. Epub 2016 Apr 7. Review.
  4. Patel JK, Schoenfeld E, Parikh PB, Parnia S. Association of Arterial Oxygen Tension During In-Hospital Cardiac Arrest With Return of Spontaneous Circulation and Survival. J Intensive Care Med. 2016 Jul 11. pii: 0885066616658420
  5. Parikh PV, Wei Y.PAHs and PM2.5 emissions and female breast cancer incidence in metro Atlanta and rural Georgia. Int J Environ Health Res. 2016 Aug;26(4):458-66. doi: 10.1080/09603123.2016.1161178. Epub 2016 Mar 17.

>> Back to Top

Dr. Hal Skopicki

  1. Szema A, McLarty A, Skopicki H, Bloom M, Jermyn R.Heart Failure: An Exploration of Recent Advances in Research and Treatment (A). Clin Med Insights Cardiol. 2015 Oct 4;9(Suppl 2):53-6. doi: 10.4137/CMC.S32652. eCollection 2015. No abstract available.
  2. Greene SJ, Epstein SE, Kim RJ, Quyyumi AA, Cole RT, Anderson AS, Wilcox JE, Skopicki HA, Sikora S, Verkh L, Tankovich NI, Gheorghiade M, Butler J. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2015 Oct 13. [Epub ahead of print]
  3. Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, Hilfiker-Kleiner D, Kamiya CA, Mazzarotto F, Cook SA, Halder I, Prasad SK, Pisarcik J, Hanley-Yanez K, Alharethi R, Damp J, Hsich E, Elkayam U, Sheppard R, Kealey A, Alexis J, Ramani G, Safirstein J, Boehmer J, Pauly DF, Wittstein IS, Thohan V, Zucker MJ, Liu P, Gorcsan J 3rd, McNamara DM, Seidman CE, Seidman JG, Arany Z; IMAC-2 and IPAC Investigators.Collaborators : H. Skopicki. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med. 2016 Jan 21;374(3):233-41. doi: 10.1056/NEJMoa1505517. Epub 2016 Jan 6.
  4. Bloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, Skopicki H, Lenihan DJ, Gheorghiade M, Lyon AR, Butler J. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging. Circ Heart Fail. 2016 Jan;9(1):e002661. doi: 10.1161/CIRCHEARTFAILURE.115.002661. Review.
  5. Hamo CE, Bloom MW, Cardinale D, Ky B, Nohria A, Baer L, Skopicki H, Lenihan DJ, Gheorghiade M, Lyon AR, Butler J. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions. Circ Heart Fail. 2016 Feb;9(2):e002843. doi: 10.1161/CIRCHEARTFAILURE.115.002843. Review.
  6. Damp J, Givertz MM, Semigran M, Alharethi R, Ewald G, Felker GM, Bozkurt B, Boehmer J, Haythe J, Skopicki H, Hanley-Yanez K, Pisarcik J, Halder I, Gorcsan J 3rd, Rana S, Arany Z, Fett JD, McNamara DM; IPAC Investigators. Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. JACC Heart Fail. 2016 May;4(5):380-8. doi: 10.1016/j.jchf.2016.01.004. Epub 2016 Mar 9.
  7. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM; ATMOSPHERE Committees Investigators. Collaborators : H. Skopicki. N Engl J Med. 2016 Apr 21;374(16):1521-32. doi: 10.1056/NEJMoa1514859. Epub 2016 Apr 4.
  8. Papadimitriou L, Smith-Jones PM, Sarwar CM, Marti CN, Yaddanapudi K, Skopicki HA, Gheorghiade M, Parsey R, Butler J. Utility of positron emission tomography for drug development for heart failure. Am Heart J. 2016 May;175:142-52.

>> Back to Top

Dr. Frank C. Seifert

  1. Carr BM, Romeiser J, Ruan J, Gupta S, Seifert FC, Zhu W, Shroyer AL. Long-Term Post-CABG Survival: Performance of Clinical Risk Models Versus Actuarial Predictions. J Card Surg. 2016 Jan;31(1):23-30. doi: 10.1111/jocs.12665. Epub 2015 Nov 5.

>> Back to Top

Dr. Kathleen Stergiopoulos

  1. Koutrolou-Sotiropoulou P, Parikh PB, Miller C, Lima FV, Butler J, Stergiopoulos K. Impact of Heart Disease on Maternal and Fetal Outcomes in Pregnant Women. Am J Cardiol. 2015 Aug 1;116(3):474-80. doi: 10.1016/j.amjcard.2015.04.063. Epub 2015 May 9.
  2. Koutrolou-Sotiropoulou P, Stergiopoulos K.Cardioembolic stroke. Acute Card Care. 2015;17(2):34-5. doi: 10.3109/17482941.2015.1066824.
  3. Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, Hilfiker-Kleiner D, Kamiya CA, Mazzarotto F, Cook SA, Halder I, Prasad SK, Pisarcik J, Hanley-Yanez K, Alharethi R, Damp J, Hsich E, Elkayam U, Sheppard R, Kealey A, Alexis J, Ramani G, Safirstein J, Boehmer J, Pauly DF, Wittstein IS, Thohan V, Zucker MJ, Liu P, Gorcsan J 3rd, McNamara DM, Seidman CE, Seidman JG, Arany Z; IMAC-2 and IPAC Investigators. Collaborators: Stergiopoulos K. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med. 2016 Jan 21;374(3):233-41. doi: 10.1056/NEJMoa1505517. Epub 2016 Jan
  4. Lima FV, Koutrolou-Sotiropoulou P, Yen TY, Stergiopoulos K. Clinical characteristics and outcomes in pregnant women with Ebstein anomaly at the time of delivery in the USA: 2003-2012. Arch Cardiovasc Dis. 2016 Jun-Jul;109(6-7):390-8.
  5. Koutrolou-Sotiropoulou P, Lima FV, Stergiopoulos K. Am J Cardiol. Quality of Life in Survivors of Peripartum Cardiomyopathy. 2016 Jul 15;118(2):258-63. doi: 10.1016/j.amjcard.2016.04.040. Epub 2016 May 5.
  6. Predisposition in Peripartum and Dilated Cardiomyopathies. Stergiopoulos K, Lima FV, Yang J. N Engl J Med. 2016 Jun 30;374(26):2601. doi: 10.1056/NEJMc1602671#SA2.

>> Back to Top